296 related articles for article (PubMed ID: 9440738)
61. Preliminary analysis of a phase II study of weekly paclitaxel and concurrent radiation therapy for locally advanced non-small cell lung cancer.
Choy H; Safran H
Semin Oncol; 1995 Aug; 22(4 Suppl 9):55-7. PubMed ID: 7644929
[TBL] [Abstract][Full Text] [Related]
62. A phase II study of concurrent chemoradiation with weekly docetaxel, carboplatin, and radiation therapy followed by consolidation chemotherapy with docetaxel and carboplatin for locally advanced inoperable non-small cell lung cancer (NSCLC).
Jain AK; Hughes RS; Sandler AB; Dowlati A; Schwartzberg LS; Dobbs T; Schlabach L; Wu J; Muldowney NJ; Choy H
J Thorac Oncol; 2009 Jun; 4(6):722-7. PubMed ID: 19404213
[TBL] [Abstract][Full Text] [Related]
63. Phase I study of vinorelbine, cisplatin, and concomitant thoracic radiation in the treatment of advanced chest malignancies.
Masters GA; Haraf DJ; Hoffman PC; Drinkard LC; Krauss SA; Ferguson MK; Olak J; Samuels BL; Golomb HM; Vokes EE
J Clin Oncol; 1998 Jun; 16(6):2157-63. PubMed ID: 9626216
[TBL] [Abstract][Full Text] [Related]
64. Prospective randomised phase II study of docetaxel versus paclitaxel administered weekly in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapy.
Esteban E; González de Sande L; Fernández Y; Corral N; Fra J; Muñiz I; Vieitez JM; Palacio I; Fernández JL; Estrada E; Lacave AJ;
Ann Oncol; 2003 Nov; 14(11):1640-7. PubMed ID: 14581272
[TBL] [Abstract][Full Text] [Related]
65. Phase I trial of weekly docetaxel combined with cisplatin in patients with non-small cell lung cancer.
Koizumi T; Tsunoda T; Fujimoto K; Nomura H; Hirai K; Koyama S; Okada K; Kubo K
Lung Cancer; 2001 Oct; 34(1):125-31. PubMed ID: 11557122
[TBL] [Abstract][Full Text] [Related]
66. Combination docetaxel/cyclophosphamide in patients with advanced solid tumors.
Valero V
Oncology (Williston Park); 1997 Aug; 11(8 Suppl 8):34-6. PubMed ID: 9364540
[TBL] [Abstract][Full Text] [Related]
67. Weekly docetaxel as II line therapy in non-small cell lung cancer: an interim analysis of a phase II study.
Valerio MR; Russo A; Latteri MA; Modica G; Gulotta G; Armata MG; Bajardi E; Cicero G; Pantuso G; Grassi N; Agosta G; Gebbia N
Lung Cancer; 2001 Dec; 34 Suppl 4():S31-5. PubMed ID: 11742700
[TBL] [Abstract][Full Text] [Related]
68. [Initial outcome of induction chemotherapy with weekly paclitaxel followed by three-dimensional conformal radiotherapy and concurrent weekly paclitaxel for stage III non-small cell lung cancer].
Wang WH; Bao Y; Chen M; Zhang L; Li KX; Xu GC; Deng XW; Lu TX; Cui NJ
Ai Zheng; 2006 Oct; 25(10):1279-83. PubMed ID: 17059776
[TBL] [Abstract][Full Text] [Related]
69. Concurrent paclitaxel/cisplatin with thoracic radiation in patients with stage IIIA/B non-small cell carcinoma of the lung.
Antonia SJ; Wagner H; Williams C; Alberts M; Hubbell D; Robinson L; Hilstro J; Ruckdeschel JC
Semin Oncol; 1995 Aug; 22(4 Suppl 9):34-7. PubMed ID: 7644926
[TBL] [Abstract][Full Text] [Related]
70. Preliminary results of a phase I study of weekly paclitaxel infusion in patients with non-small cell lung cancer.
Akerley W; Glantz M; Choy H
Semin Oncol; 1996 Oct; 23(5 Suppl 12):14-8. PubMed ID: 8941405
[TBL] [Abstract][Full Text] [Related]
71. Phase I trial of weekly docetaxel in elderly patients with non-small cell lung cancer.
Inoue A; Kunitoh H; Mori K; Nukiwa T; Fukuoka M; Saijo N
Lung Cancer; 2002 Nov; 38(2):205-9. PubMed ID: 12399134
[TBL] [Abstract][Full Text] [Related]
72. Twice-weekly paclitaxel and weekly carboplatin with concurrent thoracic radiation followed by carboplatin/paclitaxel consolidation for stage III non-small-cell lung cancer: a California Cancer Consortium phase II trial.
Lau D; Leigh B; Gandara D; Edelman M; Morgan R; Israel V; Lara P; Wilder R; Ryu J; Doroshow J
J Clin Oncol; 2001 Jan; 19(2):442-7. PubMed ID: 11208837
[TBL] [Abstract][Full Text] [Related]
73. Phase I study of docetaxel administered as a 1-hour intravenous infusion on a weekly basis.
Tomiak E; Piccart MJ; Kerger J; Lips S; Awada A; de Valeriola D; Ravoet C; Lossignol D; Sculier JP; Auzannet V
J Clin Oncol; 1994 Jul; 12(7):1458-67. PubMed ID: 7912725
[TBL] [Abstract][Full Text] [Related]
74. Concurrent two-dimensional radiotherapy and weekly docetaxel in the treatment of stage III non-small cell lung cancer: a good local response but no good survival due to radiation pneumonitis.
Onishi H; Kuriyama K; Yamaguchi M; Komiyama T; Tanaka S; Araki T; Nishikawa K; Ishihara H
Lung Cancer; 2003 Apr; 40(1):79-84. PubMed ID: 12660011
[TBL] [Abstract][Full Text] [Related]
75. Phase I studies of cisplatin and docetaxel administered by three consecutive weekly infusions for advanced non-small cell lung cancer in elderly and non-elderly patients.
Ohe Y; Niho S; Kakinuma R; Kubota K; Matsumoto T; Ohmatsu H; Goto K; Kunitoh H; Saijo N; Nishiwaki Y
Jpn J Clin Oncol; 2001 Mar; 31(3):100-6. PubMed ID: 11336320
[TBL] [Abstract][Full Text] [Related]
76. A phase I study of daily carboplatin and simultaneous accelerated, hyperfractionated chest irradiation in patients with regionally inoperable non-small cell lung cancer.
Kelly K; Hazuka M; Pan Z; Murphy J; Caskey J; Leonard C; Bunn PA
Int J Radiat Oncol Biol Phys; 1998 Feb; 40(3):559-67. PubMed ID: 9486605
[TBL] [Abstract][Full Text] [Related]
77. Phase I study of paclitaxel as a radiation sensitizer in the treatment of mesothelioma and non-small-cell lung cancer.
Herscher LL; Hahn SM; Kroog G; Pass H; Temeck B; Goldspiel B; Cook J; Mitchell JB; Liebmann J
J Clin Oncol; 1998 Feb; 16(2):635-41. PubMed ID: 9469352
[TBL] [Abstract][Full Text] [Related]
78. Concurrent paclitaxel and thoracic radiation for advanced non-small cell lung cancer.
Akerley W; Choy H
Lung Cancer; 1995 Jun; 12 Suppl 2():S107-15. PubMed ID: 7551942
[TBL] [Abstract][Full Text] [Related]
79. Docetaxel (Taxotere) in the neo-adjuvant setting in non-small-cell lung cancer.
Mattson K
Ann Oncol; 1999; 10 Suppl 5():S69-72. PubMed ID: 10582143
[TBL] [Abstract][Full Text] [Related]
80. Biweekly docetaxel as second-line chemotherapy of patients with advanced non-small cell lung cancer: a phase II study of the Galician Lung Cancer Group (GGCP 006-00).
Vázquez S; Grande C; Amenedo M; Fírvida JL; Lázaro M; Alonso G; Curiel T; Huidobro G; Mel JR; Ramos M
Anticancer Drugs; 2004 Jun; 15(5):489-94. PubMed ID: 15166623
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
